High-affinity sigma-1 protein agonist reduces clinical and pathological signs of experimental auto-immune encephalomyelitis. Oxombre B, Lee-Chang C, Duhamel A, Toussaint M, Giroux M, Donnier-Maréchal M, Carato P, Lefranc D, Zéphir H, Prin L, et al. Br J Pharmacol. 2014 Dec 17. PMID: 25521311. Abstract CommentRecommendBookmarkWatch